SGEN Seattle Genetics beats by $0.11, beats on revenue Seattle Genetics (NASDAQ:SGEN): Q3 EPS of -$0.13 beats by $0.11. Revenue of $75.85M (+6.9% Y/Y) beats by $8.93M. Shares +3.55%.